Oncology Institute Inc (TOI) — Cash Flow Reinvestment Rate
Oncology Institute Inc (TOI) has a Cash Flow Reinvestment Rate of 0.33x as of December 2025, reinvesting $1.06 Million (capex $1.06 Million ) from operating cash flow of $3.23 Million. See TOI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncology Institute Inc Cash Flow Reinvestment Rate (2018–2020)
Historical reinvestment intensity for Oncology Institute Inc across 3 annual periods. For the full cash flow conversion analysis, see TOI cash flow conversion.
Annual Cash Flow Reinvestment Rate for Oncology Institute Inc (2018–2020)
Year-by-year capital reinvestment analysis for Oncology Institute Inc. See TOI financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 19.76x | $10.04 Million | $508.00K | $1.19 Million | ▲ +2865.3% |
| 2019 | 0.67x | $2.41 Million | $3.62 Million | $1.20 Million | ▲ +18.1% |
| 2018 | 0.56x | $3.18 Million | $5.64 Million | $695.96K | — |